In the last trading session, 12.23 million Windtree Therapeutics Inc (NASDAQ:WINT) shares changed hands as the company’s beta touched 0.63. With the company’s per share price at $0.99 changed hands at -$0.2 or -16.81% during last session, the market valuation stood at $11.79M. WINT’s last price was a discount, traded about -74387.88% off its 52-week high of $737.43. The share price had its 52-week low at $0.36, which suggests the last value was 63.64% up since then. When we look at Windtree Therapeutics Inc’s average trading volume, we note the 10-day average is 30.31 million shares, with the 3-month average coming to 9.94 million.
Analysts gave the Windtree Therapeutics Inc (WINT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WINT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Instantly WINT was in red as seen at the end of in last trading. With action 25.32%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -99.46%, with the 5-day performance at 25.32% in the green. However, in the 30-day time frame, Windtree Therapeutics Inc (NASDAQ:WINT) is 80.00% up. Looking at the short shares, we see there were 0.93 million shares sold at short interest cover period of 0.17 days.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.01% of Windtree Therapeutics Inc shares while 1.39% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.39%.
Among Mutual Funds, the top two as of May 31, 2025 were Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund. With 6.67 shares estimated at $6602.0 under it, the former controlled 0.18% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.06% of the shares, roughly 2.26 shares worth around $2237.0.
